Multiple Sclerosis

Black and Hispanic patients with multiple sclerosis are underrepresented in trials, which leads to limited knowledge and understanding of the disease and treatment attributes in this population. A new study found differences among White, Black, and Hispanic patients with multiple sclerosis in terms of baseline characteristics, demographics, and disease burden. Multiple sclerosis (MS) is an...

A new study finds that ellagic acid supplementation is useful for improving the health status of multiple sclerosis patients by reducing the levels of circulating cytokines and gene expression of Tbet and RORγt, as well as increasing the gene expression of GATA3 and levels of anti-inflammatory cytokines. Multiple sclerosis (MS) is characterized by chronic immune-mediated...

Two versions can significantly reduce depressive symptoms in patients with multiple sclerosis A multiple sclerosis (MS)-specific internet-based cognitive behavioral therapy (iCBT) program can reduce depressive symptoms among patients with MS, according to a study published in the October issue of The Lancet Digital Health. Stefan M. Gold, Ph.D., from Charité-Universitätsmedizin Berlin, and colleagues conducted a...

Anti-CD20 therapies increase while mRNA vaccines decrease the risk of COVID-19 in multiple sclerosis and neuromyelitis optica patients. During the COVID-19 pandemic, concerns were raised for vulnerable patients suffering from neuroinflammatory diseases, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). MS patients showed a higher hospitalization rate with COVID-19 than the general...

Of 149 patients with baseline disability, 54 percent improved, 37 percent were stable, 9 percent deteriorated Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most patients, according to a study published online Sept. 25 in the Journal of Neurology, Neurosurgery & Psychiatry. Thomas Silfverberg, M.D.,...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 7, 2023 According to a recent study, lower socioeconomic status is linked to higher mortality rates in multiple sclerosis patients. Researchers used a large, population-based cohort to study mortality trends. Overcoming disparities in socioeconomic status could lead to improved survival rates for people with multiple sclerosis....

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 7, 2023 A recent narrative review sheds light on the racial disparities in multiple sclerosis, focusing on Black and Hispanic populations in the United States. The study recommends targeted research and interventions for these historically underrepresented groups. Multiple sclerosis affects Black and Hispanic populations differently in...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 4, 2023 A comprehensive review examined the need for more research into racial and ethnic disparities in MRI findings among multiple sclerosis patients. The study highlights the importance of diversity in clinical trials and customized treatment plans. MRI studies reveal varying lesion burdens among different racial...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on Oct. 4, 2023 A recent podcast examined the disparities in healthcare experiences and outcomes for LGBTQ+ individuals with multiple sclerosis, suggesting the need for inclusive care, improved awareness training for healthcare professionals, and further research. LGBTQ+ individuals with multiple sclerosis experience less favorable healthcare and poorer overall...